Research ExplorerPublicationsMultiplex platform technology and bioinformatics are essenti...

Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis. Reply

Standard

Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis. Reply. / Krause, Linda; Mueller, Nikola S; Eyerich, Stefanie.

In: J ALLERGY CLIN IMMUN, Vol. 139, No. 3, 03.2017, p. 1065-1066.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Krause, L, Mueller, NS & Eyerich, S 2017, 'Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis. Reply', J ALLERGY CLIN IMMUN, vol. 139, no. 3, pp. 1065-1066. https://doi.org/10.1016/j.jaci.2016.08.024

APA

Krause, L., Mueller, N. S., & Eyerich, S. (2017). Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis. Reply. J ALLERGY CLIN IMMUN, 139(3), 1065-1066. https://doi.org/10.1016/j.jaci.2016.08.024

Vancouver

Krause L, Mueller NS, Eyerich S. Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis. Reply. J ALLERGY CLIN IMMUN. 2017 Mar;139(3):1065-1066. https://doi.org/10.1016/j.jaci.2016.08.024

Bibtex

@article{8df818ebcb564355a68ac5714e7666a0,
title = "Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis. Reply",
keywords = "Biomarkers, Computational Biology, Dermatitis, Atopic, Eczema, Humans, Letter, Research Support, Non-U.S. Gov't, Comment",
author = "Linda Krause and Mueller, {Nikola S} and Stefanie Eyerich",
year = "2017",
month = mar,
doi = "10.1016/j.jaci.2016.08.024",
language = "English",
volume = "139",
pages = "1065--1066",
journal = "J ALLERGY CLIN IMMUN",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "3",

}

RIS

TY - JOUR

T1 - Multiplex platform technology and bioinformatics are essential for development of biomarkers in atopic dermatitis. Reply

AU - Krause, Linda

AU - Mueller, Nikola S

AU - Eyerich, Stefanie

PY - 2017/3

Y1 - 2017/3

KW - Biomarkers

KW - Computational Biology

KW - Dermatitis, Atopic

KW - Eczema

KW - Humans

KW - Letter

KW - Research Support, Non-U.S. Gov't

KW - Comment

U2 - 10.1016/j.jaci.2016.08.024

DO - 10.1016/j.jaci.2016.08.024

M3 - SCORING: Journal article

C2 - 28341481

VL - 139

SP - 1065

EP - 1066

JO - J ALLERGY CLIN IMMUN

JF - J ALLERGY CLIN IMMUN

SN - 0091-6749

IS - 3

ER -